baha the information company

baha is a leading provider of real-time market data, financial news, technology and solutions for the financial industry. baha offers real-time data terminals for professionals, global financial market data covering over 12 million financial instruments on more than 150 exchanges, as well as 24/7 breaking news with global coverage and free web and mobile apps. From a total of around 200 real-time data providers worldwide, only Reuters 1851, Bloomberg 1981 and now baha in 2021 were named after the founder.

DIAMEDICA INC./ CA25253X2077 /

18/01/2019 00:00:00	Chg. -	Volume	Bid-	Ask-	High	Low
4.63CAD	-	27,250 Turnover: -	4.57Bid Size: -	5.00Ask Size: -	4.90	4.56

GlobeNewswire 05/12/2019 Bioxytran’s MDX Viewer in conjunction with BXT-25 Will Validate Brain Metabolic Score as a Functiona...

GlobeNewswire 06/09/2019 DiaMedica Therapeutics to Present at Lake Street’s 3rd Annual Best Ideas Growth (BIG3) Conference on...

GlobeNewswire 03/09/2019 DiaMedica Therapeutics to Present at the 2019 Dougherty & Co. Institutional Investor Conference

GlobeNewswire 13/08/2019 DiaMedica Therapeutics Announces Second Quarter 2019 Financial Results and Provides Business Update

GlobeNewswire 12/08/2019 DiaMedica Therapeutics to Present at the 2019 Intellisight Investor Conference on August 14, 2019

GlobeNewswire 08/08/2019 DiaMedica Therapeutics to Report Second Quarter 2019 Financials and Provide a Business Update August...

GlobeNewswire 19/06/2019 DiaMedica Therapeutics Announces Interim Results from Phase 1b Trial of DM199 in Chronic Kidney Dise...

GlobeNewswire 19/06/2019 The World Market for Capnography Devices to 2026 - A $1.58 Billion Opportunity with Microstream Capn...

GlobeNewswire 22/05/2019 DiaMedica Therapeutics to Present at the 16th Annual Craig-Hallum Institutional Investor Conference ...

GlobeNewswire 21/05/2019 DiaMedica Therapeutics Announces Formation of Scientific Advisory Board for Kidney Disease

GlobeNewswire 13/05/2019 DiaMedica Therapeutics Announces First Quarter 2019 Financial Results and Provides Business Update

GlobeNewswire 06/05/2019 DiaMedica Therapeutics to Report First Quarter 2019 Financials and Provide an Update on Development ...

GlobeNewswire 30/04/2019 DiaMedica Therapeutics to Present at CKD3 Kidney Summit Meeting

GlobeNewswire 30/04/2019 Global Chronic Kidney Disease Markets and Technologies Through 2023

GlobeNewswire 19/03/2019 DiaMedica Therapeutics Announces 2018 Financial Results and Provides Corporate Update

GlobeNewswire 18/03/2019 DiaMedica Therapeutics Announces Date for the Release of Full Year 2018 Results and Conference Call

GlobeNewswire 12/03/2019 DiaMedica Therapeutics to Attend 31st Annual ROTH Investor Conference on March 18-19, 2019

GlobeNewswire 14/02/2019 DiaMedica Therapeutics Doses First Patient in Phase 1b Clinical Study of DM199 in Patients with Chro...

GlobeNewswire 23/01/2019 $1.5 Billion Capnography Devices Market - Global Market Size, Share, Development, Growth and Demand ...

GlobeNewswire 22/01/2019 DiaMedica Therapeutics Announces Publication of a Paper, “Human Tissue Kallikrein in the Treatment o...

GlobeNewswire 09/01/2019 DiaMedica Therapeutics Announces Voluntary Delisting from TSX Venture Exchange

GlobeNewswire 03/01/2019 UPDATE -- DiaMedica Announces FDA Clearance of IND Application To Study DM199 in Patients with Chron...

GlobeNewswire 03/01/2019 DiaMedica Announces FDA Clearance of IND Application To Study DM199 in Patients with Chronic Kidney ...

GlobeNewswire 07/12/2018 DIAMEDICA ANNOUNCES PRICING OF INITIAL PUBLIC OFFERING AND NASDAQ LISTING

GlobeNewswire 26/06/2018 Global Autoinjectors Market 2018-2030

DIAMEDICA INC./ CA25253X2077 /

If you wish to receive reply to your feedback, please provide your email address.